On January 30, Sitron Medical Technology Co., Ltd. released the 2017 annual results forecast. In 2017, the profit was 122.18 million yuan - 178.58 million yuan, and the profit in 2016 was 187,797,900 yuan. Decreased from the same period of the previous year: 5% - 35%.
Description of changes in performance:
During the reporting period, the company steadily carried out its main business around the business plan formulated at the beginning of the year, and the company's overall operation was developing steadily. Among them, the smart medical business grew rapidly, but the business intelligence business declined and the bad debts and goodwill impairments were accrued, resulting in a year-on-year decline in the company's overall performance.
1. During the reporting period, the company further built an innovative intelligent medical service ecosystem, and the market competitiveness of the products was further enhanced. The company's smart hospitals as the core of the smart hospital's overall solution orders for large-scale projects increased significantly, the number of orders in hand continued to increase, the company's smart medical business achieved rapid growth.
2. During the reporting period, due to the increase in R&D investment, rising raw material prices, and the company's competitive price reduction on some products after the market competition increased, the company's business intelligence business performance declined year-on-year, and the business intelligence business was accrued due to overseas customers' arrears. Bad debts and the performance of overseas investment projects did not meet expectations. The impairment of goodwill was accrued, which caused the overall performance of the company to decline year-on-year.
3. From January to December 2017, it is estimated that the impact of non-recurring gains and losses on net profit will be approximately RMB 21,200,000.
Tezacaftor Intermediate
Cas 14347-78-5 Tezacaftor Intermediate,Tezacaftor Intermediate,Cas 1004294-65-8,Cas 1638771-94-4 Tezacaftor Intermediate
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com